GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q BioMed Inc (OTCPK:QBIO) » Definitions » Days Inventory

Q BioMed (Q BioMed) Days Inventory : 0.00 (As of Feb. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Q BioMed Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Q BioMed's Average Total Inventories for the three months ended in Feb. 2023 was $0.00 Mil. Q BioMed's Cost of Goods Sold for the three months ended in Feb. 2023 was $0.00 Mil. Hence, Q BioMed's Days Inventory for the three months ended in Feb. 2023 was 0.00.

The historical rank and industry rank for Q BioMed's Days Inventory or its related term are showing as below:

QBIO's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 192.72
* Ranked among companies with meaningful Days Inventory only.

Q BioMed's Days Inventory declined from Feb. 2022 (27.13) to Feb. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Q BioMed Days Inventory Historical Data

The historical data trend for Q BioMed's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q BioMed Days Inventory Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 32.51 27.41

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.13 27.88 31.11 25.91 -

Competitive Comparison of Q BioMed's Days Inventory

For the Biotechnology subindustry, Q BioMed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q BioMed's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's Days Inventory distribution charts can be found below:

* The bar in red indicates where Q BioMed's Days Inventory falls into.



Q BioMed Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Q BioMed's Days Inventory for the fiscal year that ended in Nov. 2022 is calculated as

Days Inventory (A: Nov. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Nov. 2021 ) + Total Inventories (A: Nov. 2022 )) / count ) / Cost of Goods Sold (A: Nov. 2022 )*Days in Period
=( (0.022 + 0) / 1 ) / 0.293*365
=0.022 / 0.293*365
=27.41

Q BioMed's Days Inventory for the quarter that ended in Feb. 2023 is calculated as:

Days Inventory (Q: Feb. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Nov. 2022 ) + Total Inventories (Q: Feb. 2023 )) / count ) / Cost of Goods Sold (Q: Feb. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.003*365 / 4
=0 / 0.003*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q BioMed  (OTCPK:QBIO) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Q BioMed's Inventory Turnover for the three months ended in Feb. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Q BioMed's Inventory to Revenue for the three months ended in Feb. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Q BioMed Days Inventory Related Terms

Thank you for viewing the detailed overview of Q BioMed's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Q BioMed (Q BioMed) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
Executives
William S Rosenstadt director, 10 percent owner, officer: Chief Legal Officer ORTOLI ROSENSTADT LLP, 501 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022
Denis Corin director, 10 percent owner, officer: Chief Executive Officer 10 MARKET STREET, SUITE 427, GRAND CAYMAN E9 KY1-9006
Rick Panicucci director 501 MADISON STREET, 14TH FLOOR, NEW YORK NY 10022
Alan P Lindsay 10 percent owner 580 HORNBY STREET, FIFTH FLOOR, VANCOUVER BC CANADA V6C 2E7 A1